Jade House Recovery
COO STARTER PACK
Welcome to
Jade House
Version 0.9.1 — February 2026 (Pre-Lease Execution)
This portal shows how Jade House is building a compliance-tight, documentation-disciplined, specialty-driven outpatient operation. Launch status, DCF/REMS dependencies, unit economics, RCM guardrails, and the patient portal prototype — built to skim in minutes, with every claim tied to the financial model and licensed industry research.
Two parts to the treatment business: do the treatment right, and build the operations to keep doors open. This is the second part.
— John
Section One
Origin & Model
Jade House is designed as a rapid-access outpatient psychiatric + addiction clinic focused on:
Medication-Assisted Treatment (injectables + med management)
Interventional psychiatry (Spravato, TMS)
Evidence-based psychotherapy
Structured outpatient detox
Same-day documentation discipline (zero-day lag)
Clean RCM + clean claims from day one
Speed to intake + compliance discipline + clean claims = durable margin.
Section Two
Who's Building This
A COO needs to know who they're betting on. Here's the founding team.
John Visciano
FOUNDER & CEO
Georgetown Business, French Culinary Institute, Nova Southeastern Clinical Mental Health Counseling (2024–26). 6+ years as Group Facilitator, Case Manager, Primary Therapist at Ebb Tide Treatment Center. Florida-Certified Addiction Counselor (CAC) + CRPS-A Certified Recovery Peer Specialist. Working internship at Rebel Recovery Florida (peer support, overdose response, nonprofit ops, harm reduction). Founder capital committed (~$50K).
Dr. Barnell Phillips III
FOUNDING MEDICAL DIRECTOR (LOI SIGNED)
20+ years dual board-certified psychiatrist with added specialty in Child and Adolescent Psychiatry. Spravato, MAT, TMS certified. Sheppard Pratt training, Langley Air Force Base mental health hospital.
Jeannie Saros
CO-FOUNDER
Licensed Mental Health Counselor specializing in family therapy and trauma. 40+ years lived recovery experience.
Chris Bodh
PRIVATE INVESTOR
Private investor and early backer. Revenue share + equity conversion structure.
Patrick Dougherty
LEAD INVESTOR
Lead investor on WeFunder crowdfunding campaign.
Section Three
Why Now
MARKET CONTEXT
Florida's Medicaid behavioral health reimbursement rates increased 15% in 2024–25, making outpatient MAT + psychiatry viable for the first time. Meanwhile, Spravato and TMS are transitioning from luxury care to evidence-based standards, creating a gap for rapid-access, high-quality providers serving underserved populations.
The question a skeptical COO will ask: "If this is such a great idea, why hasn't someone already done it?" The answer: the reimbursement math didn't work until now, and the REMS/compliance overhead scared off operators who weren't willing to build the systems first.
Section Four
Launch Status
Facility Control
West Palm Beach — LOI submitted; lease in negotiation.
5,091 SF · Parking ratio: 6 per 1,000 sq ft
Target: Execute lease + proof of control → unlock DCF site steps
Strong access + timeline; maintained as backup until lease executed.
Phased activation optionality.
Watch-outs: life safety/egress constraints for phased occupancy; humidity/mold risk if mothballed.
Potential speed advantage if zoning/use classification + parking interpretation are clean.
PROPOSED LAYOUT
Suite 320 — 5,091 SF Floor Plan
Clinical
5 rooms
Specialty
2 rooms
Admin
4 rooms
Shared
6 rooms
CLINICAL ZONE
Exam 1 — Medical intake & assessment
Exam 2 — Medical intake & assessment
Therapy 1 — Individual sessions
Therapy 2 — Individual sessions
Flex / Therapy 3 — Overflow / groups
SPECIALTY / INTERVENTIONAL
Spravato / TMS 1 — REMS-compliant treatment bay
Spravato / TMS 2 — REMS-compliant treatment bay
2-hour monitoring capacity per bay. Dual-use for TMS daily sessions.
ADMINISTRATION
CEO Office
COO Office
MD Office — Medical Director
NP / PA Office
SHARED / SUPPORT
Conference Room — Team meetings, staffings
Group Room & Events — Group therapy, community
Kitchen — Staff break area
Clinical Director Office
Case Mgr / Peer Office
Admit / Outreach Station
CAPACITY NOTE:Layout supports 17 distinct functional areas across 5,091 SF. Dual Spravato/TMS bays enable concurrent interventional sessions. Group room doubles as community event space for referral partner engagement.
Controlled-Document Note: Current policy manual address fields are placeholders. Upon executed lease, we will trigger a single controlled-document update (policy manual + evacuation routes + signage + DCF packet + payer enrollment profiles). No licensure or DEA documentation will rely on placeholder addresses.
Licensure + Compliance
DCF licensure sequencing mapped
Spravato REMS workflow built into clinical model
Documentation completion SLA: 24–48 hours
Authorization + front-end eligibility controls embedded in intake workflow
LAUNCH GATING ITEMS
Executed lease
Final floorplan approval
Proof of control submission to DCF
Final vendor install scheduling
Section Five
Capital & Runway
Sources & Uses (high-level snapshot)
Capital Stack (as of February 22, 2026)
$350K SECURED CAPITAL
WeFunder crowdfund ($100K) + private investment ($200K from Chris Bodh) + founder capital ($50K)
$300K–$500K CAPITAL RAISE IN PROGRESS
Personal line of credit ($100K–$200K)
HIGH PROBABILITY
Private equity investors via professional network ($200K–$300K)
MEDIUM-HIGH PROBABILITY
Additional strategic commitments ($100K+)
Exploring
$350K–$500K FLEXIBLE EQUITY CAPACITY
Jade House can raise an additional $350K–$500K from equity investors at any time, which would retire or offset any outstanding or pending debt, giving the company a debt-free or debt-light launch posture if preferred.
BRIDGE FINANCING CONVERSATIONS ACTIVE
SoFi, Ready Capital, and LOC structures under evaluation; equity-first strategy prioritized to minimize debt burden.
$2,230,987
Total Projected Sales
Projections based on Medicaid reimbursement rates + conservative 60% capacity utilization (see Financial Model for assumptions).
55–60
Active patients at break-even
Cash Discipline
Front-end auth required before service
Documentation completion within 48 hours
Weekly denial review cadence
DSO monitored against 45-day base / 60-day stress scenario
RCM Partner: Coronis Health — full-service revenue cycle management with behavioral health specialization. Handles credentialing, claims submission, denial management, and payer follow-up so the clinical team stays focused on care.
NOTATION
Industry benchmarks are cited where applicable. All other figures are financial model assumptions (Feb 2026) and will be re-baselined after payer contracting + first 60 days of live claims.
Section Six
Service Mix
Year 1 Revenue Mix (Feb 2026)
Total Projected Sales: $2,230,987Specialty Care
Primary revenue driver. Includes MAT injectables (Sublocade/Vivitrol), Spravato, TMS, psychiatric evaluations, medication management (moderate/low intensity), injection administration, and ambulatory detox per diem.
Therapy Services
Individual therapy, group therapy, and telehealth sessions. Standard outpatient behavioral health delivery.
External Services
SEFBHN contracted services (est. 2027) + training/consulting revenue (likely partnerships or community education).
Support Services
Case management. Essential for continuity of care but low-margin.
THE BOTTOM LINE
You're betting on Specialty Care (interventional psychiatry + MAT) to carry the house. That's the right call for South Florida's underserved market — Medicaid/managed care will reimburse Spravato/Sublocade aggressively if you nail the prior auth game. Therapy and external contracts provide stability, but the margin lives in the specialty interventions.
Gaps & Risks
Spravato REMS execution is the single biggest operational risk in this mix. If you don't have airtight workflows for monitoring, documentation, and adverse event response, you'll lose revenue or worse, your ability to bill the service.
Payer mix assumption: This assumes strong Medicaid/managed Medicaid penetration. If commercial insurance becomes a larger share, margins improve — but so does prior auth complexity.
TMS volume: TMS is capital-intensive and requires daily patient throughput for 4–6 weeks. Do you have the referral pipeline to fill those chairs?
Risk Mitigation — Already in Progress
Spravato REMS: Full REMS SOP drafted. Monitoring checklist, adverse event protocol, and documentation templates built before first patient.
Payer mix concentration: Parallel credentialing with Aetna, Cigna, and UHC commercial panels. Medicaid is the floor, not the ceiling.
TMS referral pipeline: Dr. Phillips' existing referral network + SEFBHN partnership (est. 2027) provides warm pipeline. Marketing budget allocated for psychiatrist outreach in Month 1.
Rx inventory & capital protection: Launching with specialty pharmacy fulfillment (white-bagging) for the first 6–9 months to eliminate upfront drug inventory costs and protect working capital. Once capitalization is secured, converting to buy-and-bill to capture the full drug margin — improving reimbursement on observation and other billing codes by an additional ~40%.
Pharmacy Strategy
Most behavioral health operators stumble into Spravato fulfillment without understanding the cash trap. White-bagging (specialty pharmacy bills drug directly to payer, clinic bills admin/observation) eliminates the $64K+ inventory float risk that kills early-stage cash flow. But it caps your margin.
The smart play: launch Month 1–6 with white-bag to prove clinical volume and payer reliability, then flip to buy-and-bill Month 7+ once you've got $100K working capital buffer and proven 30-day collection cycles. A COO who gets margin levers will immediately see this as disciplined staging, not indecision.
FULFILLMENT CONVERSION TIMELINE
MONTH 1–6
MONTH 7+
WHITE-BAG MODEL
Specialty pharmacy ships drug to clinic
Pharmacy bills payer for drug cost
Clinic bills observation + admin only
Zero drug inventory on balance sheet
Protects working capital during ramp
BUY-AND-BILL MODEL
Clinic purchases drug directly
Clinic bills payer for drug + admin
Negotiate volume pricing with manufacturer
Capture full drug margin on every session
Requires $100K+ working capital buffer
CONVERSION TRIGGER:$100K working capital buffer confirmed + 30-day collection cycle proven + minimum 20 Spravato sessions/month sustained
SPRAVATO UNIT ECONOMICS — PER MAINTENANCE SESSION
WHITE-BAG MODEL
BUY-AND-BILL MODEL
MARGIN DELTA
+$300 per session
AT 40 SESSIONS / MONTH
+$12,000 monthly
But only if you've got the cash reserves to float inventory and absorb 45–60 day collection cycles without choking operations. That's why the staging matters.
Section Seven
Operating System
Intake → Treatment → Documentation → Claim
Access Discipline
Same-day callback standard
72-hour intake target
No-show salvage protocol
Documentation Discipline
24–48 hour completion SLA
Modifier-25 applied correctly when E/M is billed with injection
Injection inventory reconciliation weekly
Monthly 10-day close (bills reconciled before payroll run)
RCM Guardrails
Eligibility verified before service
Authorization logged before scheduling
Denial root-cause tracking weekly
Target denial rate: ≤10%
Target A/R days: <30
Section Nine
Patient Portal Prototype
12-screen interactive portal:
Admission workflow
Consents
Mood tracking (Kipu outcomes sync)
Messaging
Medication tracking
Scheduling
SOS
Goals
Referrals
Preview
The patient portal is not marketing — it is an operational extension of documentation, engagement, and retention discipline.
Section Ten
The Bottom Line
Jade House is not betting on a single procedure.
It is building a compliance-tight, documentation-disciplined, specialty-driven outpatient engine.
The treatment must work.
The business must stay open.
This portal shows how both are being built — in parallel.
NEXT STEPS
Schedule lunch next week — Mon/Tues 2pm+, Wed 3pm+. We'll sketch out hiring, marketing, and investor strategy. Facility lease negotiations wrapping by week's end.
Jade House Recovery
John Visciano, Founder & CEO
917-960-1508
Prepared February 2026 — Confidential